Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Ltd | Sector: Pharmaceuticals | ISIN: INE154G01022

Corporate Actions

19 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

19 Jan , 2023

12:00 AM

Results

27 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

27 Oct , 2022

12:00 AM

Results

19 Sep , 2022

12:00 AM

AGM

Announcement date: 19 Sep , 2022

02 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

02 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

25 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

25 Jul , 2022

12:00 AM

Results

18 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

31 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

31 Jul , 2022

12:00 AM

Results

19 Sep , 2022

12:00 AM

BookCloser

Venmax Drugs & Pharmaceuticals Ltd News and Update

Image not found

Union Budget 2023-2024 Reaction: Mr. Dinanath Dubhashi, Managing Director & CEO, L&T Finance H...

12 hours ago |
2:50 PM

Today's Budget has every potential to bring out a broad-based revival in the Indian economy.

Union Budget 2023-2024 Reaction: Manish Dabkara, Chairman and MD EKI Energy...

IIFL News Service |
12 hours ago |
2:50 PM

ITC opens new food manufacturing and logistics facility worth Rs450 crore i...

IIFL News Service |
1 day ago |
2:49 PM

Mr. Dhirup Roy Choudhary, MD & CEO, HIL Ltd

IIFL News Service |
30 January, 2023 |
2:47 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	1,016.90	93.82	2,43,328.56	486.73	0.99	4,549.90	108.48
Divis Laboratories Ltd	3,355.85	30.01	89,087.27	486.85	0.89	1,823.38	454.85
Cipla Ltd	1,032.05	30.11	83,321.47	678.52	0.48	3,541.16	291.76
Dr Reddys Laboratories Ltd	4,350.50	30.70	72,446.20	324.60	0.69	3,879.60	1,156.24
Torrent Pharmaceuticals Ltd	1,538.50	49.49	51,907.38	229.00	1.57	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.